Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Business

Channels:

Utrafast Imaging, Smallest Transistor, Electronic Cyclones, Sensor-Filled Glove, and More in the Engineering News Source

The latest research and features in the Newswise Engineering News Source

Medicine

Channels:

Glioblastoma, Brain Cancer, Malaria, Chloroquine, University Of Colorado Cancer Center, jean mulcahy-levy

Malaria Drug Successfully Treats 26-Year-Old Brain Cancer Patient

Mulcahy.w.Patient.png

Small trial uses chloroquine to nix the process of "autophagy" that some cancer cells use to resist treatment, resensitzing glioblastoma to targeted therapy

Medicine

Channels:

Smoking and cancer, Lung Cancer

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Slide1.jpg

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.

Medicine

Science

Channels:

Nanoparticles, Drug Delivery Systems, Brain Injury

A Simple Sniff

A team of engineers from Washington University in St. Louis has combined nanoparticles, aerosol science and locusts in new proof-of-concept research that could someday vastly improve drug delivery to the brain, making it as simple as a sniff.

Medicine

Channels:

Duchenne, Duchenne Muscular Dystrophy, DMD, Muscular Disorders, Muscular Diseases, Kennedy Kreiger Institute, Center for Genetic Muscular Disorders, Kathyrn Wagner, Dr. Kathryn Wagner, Research, Clinical Trials

Families of Boys with Duchenne Muscular Dystrophy Band Together to Fund Research

Ryan’s Quest, Michael’s Cause and Pietro’s Fight are non-profits founded by families of boys with Duchenne muscular dystrophy who believe that their global collaboration is paramount to see potential therapies through the drug pipeline.

Medicine

Channels:

Alzheimber's Disease, Dementia, Amyloid Beta, Pet Imaging, Memory Disorders, Prevention

Focus on Alzheimer’s Disease Shifts to Prevention

RS9228_erik_roberson_2008_1.jpg

UAB physicians say prevention, not cure, may be the key to coping with the rising incidence of Alzheimer's disease. New imaging techniques, coupled with a better understanding of the disease, provide new hope.

Medicine

Channels:

GW School of Medicine and Health Sciences, Cystic Fibrosis, Thymosin, Thymosin Alpha 1, University of Perugia, University of Rome, Biochemistry, Molecular Medicine, Genetics, Pediatrics, CF, respiratory conditions

Research Uncovers Potential New Treatment to Treat and Stop Progression of Cystic Fibrosis

Researchers published in Nature Medicine from the George Washington University, the University of Perugia, and the University of Rome have discovered a potential new drug to treat and stop the progression of cystic fibrosis. Thymosin α1 is a novel therapeutic single molecule-based therapy that not only corrects genetic and tissue defects, but also significantly reduces inflammation seen in cystic fibrosis patients.

Medicine

Channels:

Immunotherapy, Melanoma, Immune Response

Matching Pre-Treatment Tumor Size to Strength of Immune Response Allows Tailoring of Melanoma Drug Regimen

A new study published in Nature provides clues that could enhance physicians’ ability to pinpoint, in real-time, which patients are not responding to therapy – and intervene with additional drugs to boost the chances of shrinking tumors.

Medicine

Life

Social and Behavioral Sciences

Channels:

long-term effects of antibiotics, early-life antibiotic exposure, Penicillin

Low-Dose Penicillin in Early Life Induces Long-Term Changes in Behaviour

The researchers report that low-dose penicillin taken late in pregnancy and in early life of mice offspring, changes behaviour and the balance of microbes in the gut. While these studies have been performed in mice, they point to popular increasing concerns about the long-term effects of antibiotics.

Medicine

Channels:

ENDO 2017, Endocrine Society, Menopausal Hormone Therapy, Menopause, Bioidentical Hormones, Compounding, Hot Flash, Hot Flashes, Phase 3 clinical trial

New Natural Estrogen-Progesterone Capsule Reduces Postmenopausal Hot Flashes

A natural, or bioidentical, combined estradiol-progesterone capsule (TX-001HR) significantly decreases the frequency and severity of moderate to severe hot flashes in postmenopausal women, the Replenish study finds. Results of this phase 3, randomized, placebo-controlled, multicenter trial will be presented Monday at ENDO 2017, the Endocrine Society’s 99th annual meeting in Orlando, Fla.







Chat now!